Search
for
Sort by
Research 91–120 of 1000+
- The pathophysiology of delayed ejaculation
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Post-finasteride syndrome – does it really exist?
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Effects of 5-alpha reductase inhibitors
- Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Review Article: Practical Aspects of Testosterone Deficiency Syndrome in Clinical Urology
- Androgen antagonists in androgen target tissues
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Chapter 6. Darwinian Health and Other Contradictions
- Finasteride
- Clinical applications of antiandrogens
- Men??s Health
- Dihydroartemisinin attenuates benign prostatic hyperplasia in rats by inhibiting prostatic epithelial cell proliferation
- Postoperative Urinary Retention is an Independent Predictor of Short-Term and Long-Term Future Bladder Outlet Procedure in Men
- Hormonal manipulation of benign prostatic hyperplasia
- Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential
- CLINICAL OBSERVATION: HYPONATREMIA ASSOCIATED WITH DIURETIC USE AND URINARY RETENTION IN AN OLDER MAN
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved]
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Recent advances in treatment for Benign Prostatic Hyperplasia
- Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- Dual deficiency of melatonin and dihydrotestosterone promotes stromal cell damage and mediates prostatitis via the cGAS-STING pathway in sleep-deprived mice